-
Study aim
-
Investigating the effect of anesthesia without drugs on the condition of patients undergoing thoracoscopic chest surgery
-
Design
-
In this study, which will be conducted in phase 3 of the clinical trial, a number of 60 patients, according to the entry and non-entry criteria and after obtaining the consent certificate for participation in the study, were randomly (using permuted blocks) and one-sidedly blinded to Two intervention groups (number = 30) and control (number = 30) will be divided. Patients of both groups will be operated by the same surgical and anesthesia team.
-
Settings and conduct
-
This study will be conducted in phase 3 of the clinical trial randomly (using permuted blocks) and one-sidedly blinded on patients who are candidates for thoracostomy surgery referring to Masih Daneshvari Hospital.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements
Candidate for thoracoscopic surgery
- 18 < age < 70 years
Non-entry conditions:
Sensitivity to ketamine, sensitivity to dexmedetomidine, symptoms of increased ICP or history of cardiovascular diseases, active gastric ulcer, active GIB bleeding, liver and kidney failure, history of drug and alcohol addiction, corticosteroid use in the two weeks leading to surgery
-
Intervention groups
-
In the control group: induction of anesthesia with the continue method (prescribing fentanyl and midazolam, atracurium and propofol to induce anesthesia and to maintain isoflurane gas) will be used.
In the intervention group: induction of anesthesia using midazolam, atracurium, propofol and ketamine and maintenance using isoflurane gas and dexmedetomidine will be done.
-
Main outcome variables
-
Type of medicine used during surgery; Type of medicine used after surgery; duration of surgery; Duration of anesthesia; Recovery time; Duration of hospitalization in ICU; Complications after surgery